Dr. Steven Salzman

D.D.S. | Dentist



  
  6444 W Belmont Ave, Unit A, Chicago
  Illinois, 60634-4189

  773-777-6788    Maps & Directions
Dr. Steven Salzman is a Chicago, Illinois based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 6444 W Belmont Ave, Unit A, Chicago. Patients can reach him at 773-777-6788.
Dr. Steven Salzman is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Steven Salzman speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Steven Salzman
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:6444 W Belmont Ave, Unit A, Chicago,
Illinois, 60634-4189
Phone:773-777-6788
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 3870813975
Enrollment ID: I20150513000340
NPI Number: 1205058013
NPI Enumeration Date: 02 May, 2007
NPI Last Update On: 06 Jul, 2015

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 6444 W Belmont Ave, Unit A
Chicago, Illinois
Zip: 60634-4189
Phone Number: 773-777-6788
Patients can reach Dr. Steven Salzman at 6444 W Belmont Ave, Unit A, Chicago, Illinois or can call to book an appointment on 773-777-6788. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: